跳至主要内容
临床试验/NCT00274430
NCT00274430已完成1 期

A Randomized Controlled Trial of the Effects of Tadalafil and Dexamethasone Versus Placebo on Pulmonary Edema Formation and Cerebral Blood Flow Autoregulation in High Altitude Newcomers With a Previous History of High Altitude Pulmonary Edema

University of Zurich0 个研究点目标入组 30 人开始时间: 2003年7月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
30
主要终点
prevention of high altitude pulmonary edema

研究概览

简要总结

A double-blind placebo controlled study

  • To compare the effect of tadalafil and dexamethasone versus placebo on Ppa and pulmonary edema formation in subjects susceptible to HAPE.
  • To investigate the effect of dexamethasone on alveolar fluid clearance, as assessed by measurement of the nasal potential difference, and prevention of HAPE.
  • To investigate the effect of the tadalafil and dexamethasone versus placebo on the dynamic CBF autoregulation properties and on the development of AMS in HAPE susceptible subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • At least one previous episode of high altitude pulmonary edema

排除标准

  • pulmonary arterial hypertension
  • congenital heart disease
  • any chronic lung disease

结局指标

主要结局

prevention of high altitude pulmonary edema

次要结局

  • incidence of acute mountain sickness

研究者

申办方类型
Other

相似试验